Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Harness Advanced Genomics to Personalize Breast Cancer Care

The Oncotype DX® family of breast cancer tests provide a thorough view of each patient’s unique tumor.

Every patient is different. That means every tumor is different. With the genomic-based insights of Oncotype DX tests, you can make informed decisions with actionable data customized to each patient’s situation.

Oncotype DX Breast Cancer test

The intelligent test for early-stage breast cancers

Order a Test

Tests are available through our physician portal. Simply request a specimen kit to submit a sample by calling +1 866-ONCOTYPE (+1 866-662-6897) prior to completing a requisition form on the portal. Once you order, we then work with the pathology team or treating physician to obtain the sample using the specimen kit.

How to order the Oncotype DX Breast Recurrence Score® test